Home Business India/UK joint move to stem illegal medicine trade

India/UK joint move to stem illegal medicine trade

7
0
SHARE
 by .

UK seeks the help of Indian officials to tackle the entry of unlicensed medicines into the UK….reports Asian Lite News

 by . The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) are working closely with law enforcement agencies in India to prevent unlicensed medicines entering the UK. 

Following a meeting in Delhi earlier this month, MHRA will send intelligence to India’s Directorate of Revenue Intelligence (DRI), enabling them to target regions suspected of sending unlicensed medicines into the UK.

This is another example of co-ordinated efforts to tackle international medicines crime. The DRI recently seized 350,000 tablets of potent medicines such as Zopiclone, Zolpidem, Lorazepam, Diazepam, Tramadol and Alprazolam destined for UK, European and US markets. Rapid mutual intelligence-sharing will help to combat the illegal cross-border trade in medicines.

The DRI recently seized 350,000 tablets of potent medicines such as Diazepam, Tramadol and Zopiclone destined for UK, European and US markets.

The UK and India have a longstanding relationship when it comes to collaborating around the issue of medicines. In 2015 both countries signed a Memorandum of Understanding (MOU), further increasing collaboration in the area of medicines and medical devices and improving public safety. 

 by .  “Our active collaboration with Indian Government agencies sends a strong message to criminals; when we work with our global partners we are able to disrupt criminal activity through the identification, arrest and prosecution of offenders wherever they are,” said Alastair Jeffrey, MHRA’s Head of Enforcement. “We are working tirelessly to identify all those involved in bringing unlicensed medicines into the UK. Our collaborative efforts with key partners like India will help protect the health of UK citizens.”

   “Indian Customs is committed to detecting and preventing illegal cross border trade in medicines and psychotropic substances,” said Vivek Chaturvedi, Additional Director General, DRI.

DRI being the apex intelligence and investigative agency has successfully booked a number of cases, carried out seizures and arrested offenders in recent past.

“DRI works closely with international law enforcement agencies and regulators and MHRA is an important partner in tackling the menace of trade in illegal medicines. Such collaboration is mutually beneficial to both countries in protecting the health of their citizens and in prosecuting the criminals involved in such offences.”